Prediction of In Vivo Drug Clearance from In Vitro Data, I: Impact of Inter-individual Variability Publication Prediction of In Vivo Drug Clearance from In Vitro Data, I: Impact of Inter-individual Variability The Simcyp® Population-Based ADME Simulator was used to predict median drug clearances and their associated…CertaraJune 1, 2006
Prediction of In Vivo Drug Clearance from In Vitro Data, II: Potential Inter-ethnic Differences Publication Prediction of In Vivo Drug Clearance from In Vitro Data, II: Potential Inter-ethnic Differences Potential differences in drug clearance between Japanese and Caucasians were investigated by integrating data on…CertaraJune 1, 2006
Development of a Predictive Pharmacokinetic Model for a Novel Cyclooxygenase-2 Inhibitor Publication Development of a Predictive Pharmacokinetic Model for a Novel Cyclooxygenase-2 Inhibitor A predictive population pharmacokinetic model was developed for a novel cyclooxygenase-2 (COX-2) inhibitor CS-706, using…CertaraMay 1, 2006
Enriched Analgesic Efficacy Studies: An Assessment by Clinical Trial Simulation Publication Enriched Analgesic Efficacy Studies: An Assessment by Clinical Trial Simulation The aim of this study was to develop a pain relief model for a cyclooxygenase…CertaraApril 1, 2006
Changes in Liver Volume from Birth to Adulthood: A Meta-analysis Publication Changes in Liver Volume from Birth to Adulthood: A Meta-analysis A diversity of equations is available for the estimation of liver volume (LV), derived from…CertaraDecember 1, 2005
Kinetic Values for Mechanism-based Enzyme Inhibition: Assessing the Bias Introduced by the Conventional Experimental Protocol Publication Kinetic Values for Mechanism-based Enzyme Inhibition: Assessing the Bias Introduced by the Conventional Experimental Protocol The in vitro characterisation of a mechanism-based enzyme inactivator (MBEI) includes determination of the maximum…CertaraNovember 1, 2005
Model-based Development of Gemcabene, a New Lipid-altering Agent Publication Model-based Development of Gemcabene, a New Lipid-altering Agent The purpose of this study was to evaluate the value of model-based, quantitative decision making…CertaraOctober 7, 2005
Model-based Covariate Pharmacokinetic Analysis and Lack of Cortisol Suppression by the New Inhaled Corticosteroid Ciclesonide Using a Novel Cortisol Release Model Publication Model-based Covariate Pharmacokinetic Analysis and Lack of Cortisol Suppression by the New Inhaled Corticosteroid Ciclesonide Using a Novel Cortisol Release Model Ciclesonide is a novel and effective inhaled corticosteroid for the treatment of asthma that is…CertaraSeptember 1, 2005
Therapeutic Benefit of Eletriptan Compared to Sumatriptan for the Acute Relief of Migraine Pain—Results of a Model-based Meta-analysis that Accounts for Encapsulation Publication Therapeutic Benefit of Eletriptan Compared to Sumatriptan for the Acute Relief of Migraine Pain—Results of a Model-based Meta-analysis that Accounts for Encapsulation A novel model-based meta-analysis was used to quantify the dose-response relationship of sumatriptan and eletriptan…CertaraSeptember 1, 2005
Modelling Approaches to Dose Estimation in Children Publication Modelling Approaches to Dose Estimation in Children Most of the drugs on the market are originally developed for adults and dosage selection…CertaraJune 1, 2005